CDMO Services

Contract Development & Manufacturing Services

Immorna offers one-stop-shop contract development manufacturing (CDMO) services, based on our proprietary RNA and LNP platforms. Development and manufacturing using customers' unique platforms is also available after technology transfer.

Services span from sequence design, customized analytical assay development/qualification, DNA template manufacturing, mRNA/LNP production and purification, to fill-finish and QC release.

Integrated analytical and stability services support rapid transition of development programs from pre-clinical to clinical stage.

Strength in Development


  • Expert staff with biotech, big pharma and CDMO backgrounds
  • Pre-clinical and clinical development of RNA vaccines, immuno-oncology products and therapeutics
  • Successful IND applications with US FDA


  • Conventional (non-replicating) and self-replicating RNA platforms
  • Early and late stage development program support; 1 mg to 5 g RNA processing scale
  • LNP formulation and lyophilization capabilities
  • Options to utilize Immorna platforms or customer-developed processes


  • Typical lead time from DNA plasmid to DP fill/finish in 4 weeks
  • Internal capability for expedited Toxicology and GMP batch manufacturing

Strength in Manufacturing

Proprietary RNA and LNP Platforms

  • Highly potent RNA vectors
  • LNP formulations based on proprietary lipids
  • High quality DS and DP with CQAs monitored using qualified analytical assays
  • Established GMP capabilities with up to 5g RNA manufacturing scale for bulk RNA Drug Substance and formulated Drug Product

GMP Manufacturing Track Record

  • Over 30 Tox & GMP batches successfully manufactured and released
  • Multiple US FDA IND clearances received

Integrated GMP Services

  • Over 20,000 sf GMP facility
  • Master and Working Cell Bank manufacturing
  • Platform processes for plasmid, RNA and LNP production and purification
  • Comprehensive analytical panels for QC release and charaterization
  • Developmental and GMP stability studies

Services Offered

Proprietary conventional and self-replicating RNA and LNP platforms
Customized process development
Research grade material production
Toxicology study material manufacturing and release
Clinical trial material (CTM) manufacturing and release
GMP and developmental stability studies and testing
Customized analytical assays (both release a characterization), development and qualification
IND filing support

Learn More

  • First Name*
  • Last Name*
  • Email Address*
  • Company Name*
  • Enter code shown below*
  • By sharing your data, you are agreeing to our Privacy Policy.